Screening of biomarkers using gene expression profiling in peripheral blood of severely septic patients
Not Applicable
- Conditions
- Severe sepsis
- Registration Number
- JPRN-UMIN000014502
- Lead Sponsor
- Graduate School of Medicine, Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are onsidered inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Significant alteration of time-dependent expression in severe sepsis
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular biomarkers are identified in peripheral blood for severe sepsis using gene expression profiling in JPRN-UMIN000014502?
How does gene expression profiling in JPRN-UMIN000014502 contribute to understanding sepsis pathophysiology and potential drug targets?
Are there specific gene signatures in peripheral blood that correlate with clinical outcomes in severe sepsis patients from JPRN-UMIN000014502?
What are the potential adverse events associated with biomarker screening in peripheral blood for severe sepsis management?
How does the observational approach in JPRN-UMIN000014502 compare to other trials in identifying sepsis biomarkers for patient stratification?